Search results (1275)
« Back to NewsNew research reveals shared genetic link between endometriosis and immune conditions
29 April 2025
Research published in the journal Human Reproduction reveals that women with endometriosis are at a significantly higher risk for developing a range of autoimmune, autoinflammatory, and mixed-pattern diseases.
Celebrating 10 years of International Health and Tropical Medicine (IHTM)
28 April 2025
On the 25 and 26 April the MSc in International Health and Tropical Medicine, IHTM, celebrated its tenth anniversary as an internationally renowned programme for future global health leaders, with over 100 alumni travelling from around the world to join colleagues, current students and guests in Oxford.
Study shows urgent change needed to reduce deaths from malaria and meningitis in comatose African children
25 April 2025
Results of two parallel studies show that one in four African children hospitalised with malaria and coma have an additional infection, and that giving antibiotics with antimalarials could help reduce death rates of comatose children.
Study finds that Treg depletion suppresses tumour growth
24 April 2025
A new study, co-lead by Dr Felipe Galvez-Cancino from the Centre for Immuno-Oncology, has shown that Treg cell depletion can suppress tumour growth in one of the deadliest types of cancer.
Collaborative research project awarded Pancreatic Cancer UK grant
24 April 2025
Academic Clinical Lecturer Mr Keaton Jones has been awarded a grant from Pancreatic Cancer UK to carry out pioneering pancreatic cancer research within the Nuffield Department of Surgical Sciences.
New Study Finds Common Virus May Improve Skin Cancer Treatment Outcomes
23 April 2025
A new study led by the University of Oxford has revealed that a common and usually harmless virus may positively influence how skin cancer patients respond to current treatments.
Child heart disease may be more likely if mother has anaemia during pregnancy
23 April 2025
New research shows the chance of a child having congenital heart disease increases if the mother is anaemic during pregnancy.
New ultrasound drug delivery system found to be highly effective against bacterial biofilms
22 April 2025
Researchers at the University of Oxford have developed a new drug delivery system using ultrasound-activated nanoparticles to break through and destroy bacterial biofilms. This offers a promising solution that could address the global crisis of chronic antibiotic-resistant infections affecting hundreds of millions of people worldwide.
Novel insights and perspectives into diabetes and obesity medications (GLP-1RAs) to treat dementia
16 April 2025
Researchers have conducted an extensive review of studies of GLP-1RAs like semaglutide, better known as Ozempic or Wegovy.
Scientists discover 25 genetic links to infertility in women and men
14 April 2025
A study led by researchers from the University of Oxford’s Big Data Institute has identified 25 genetic variants linked to infertility and 269 that are linked to hormones that can affect fertility.
Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) leads study on burosumab for adults with rare inherited disorder
10 April 2025
NDORMS researchers have been awarded funding to explore the long-term effects of burosumab in adults with X-linked hypophosphataemia (XLH).
Study identifies direct link between inflammation and asthma attacks
10 April 2025
An international consortium of respiratory scientists, including researchers from the Nuffield Department of Medicine’s Experimental Medicine Division, have shed light on the role of inflammation in asthma. Through their findings, they have provided a new way of predicting and preventing asthma attacks.
Addressing healthcare workforce challenges with new research partnership
9 April 2025
Researchers from the Nuffield Department of Primary Care Health Sciences are part of a major new research initiative aimed at tackling critical workforce challenges in healthcare, particularly in underserved communities.
Up to £16.5 million awarded to global consortium to overcome obstacles in infectious disease research
9 April 2025
The International Severe Acute Respiratory and emerging Infection Consortium (ISARIC) has been awarded up to £16.5 million to build on its globally-recognised efforts to prevent illness and deaths from epidemic-prone infectious diseases.
Blood cancer patients should continue treatment at time of COVID-19 vaccination, Oxford Clinical Trials Research Unit study shows
9 April 2025
Evidence shows for patients with a type of leukaemia, pausing BTKi therapy for COVID-19 vaccination does not improve antibody responses to the vaccine
Boosting vaccines with harmless bacteria to fight intestinal pathogens
4 April 2025
Published in Science, a ground-breaking study by the Slack group reveals how combining vaccines with friendly bacteria can boost vaccination efficacy and potentially reduce reliance on antibiotics.
The Kenya Medical Research Institute (KEMRI) signs landmark partnership with Wellcome and Oxford
3 April 2025
The Kenya Medical Research Institute (KEMRI) has officially entered into a seven-year Memorandum of Understanding (MoU) with Wellcome, a UK-based charitable foundation, and the University of Oxford. The £91 million agreement was signed at the Wellcome headquarters in London, marking a significant boost for medical research and training in Kenya.
New international guidelines for the treatment of schizophrenia
2 April 2025
Researchers from all regions of the UN have developed a set of consensus guidelines for the treatment of schizophrenia.
Study reveals one in ten people feel NHS has caused them harm
1 April 2025
One in ten people surveyed reported that the NHS has caused them physical or emotional harm, according to a new study by researchers at Oxford Population Health and the London School of Hygiene & Tropical Medicine (LSHTM). The study is published in BMJ Quality & Safety.
New paper on sleep published in Current Biology by members of the Vyazovskiy Group and colleagues
1 April 2025
This study reports novel fundings from a mouse model called rlss (for restless) of deficient synaptic neurotransmission, that results from a mutation in one of the key SNARE proteins VAMP2.